A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with a diabetic foot ulcer and meet the inclusion/exclusion criteria
Type I or Type II diabetes with investigator-confirmed reasonable metabolic control
A full thickness diabetic plantar foot ulcer of at least 1 cm2 but not exceeding 10 cm2 in area
An ulcer which has been in existence for a minimum of 30 days, prior to the day of screening
Suspected or confirmed signs/symptoms of wound infection